NuVasive (NUVA) PT Lowered to $67 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
NuVasive (NUVA) PT Lowered to $68 at BTIG
August 1, 2018 6:15 AM EDTBTIG lowered its price target on NuVasive (NASDAQ: NUVA) to $68.00 (from $72.00) while maintaining a Buy rating.
... MoreNuVasive (NUVA) Reports In-Line Q2 EPS, Revenues Beat; Offers FY18 EPS Outlook Below Consensus
July 31, 2018 4:41 PM EDTNuVasive (NASDAQ: NUVA) reported Q2 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $281 million versus the consensus estimate of $276.26 million.
Second Quarter 2018 Highlights
Revenue increased 8.5% to $281.6 million, or 7.7% on a constant currency basis;GAAP operating profit margin of 10.1%; Non-GAAP operating profit margin of 16.3%; andGAAP diluted earnings per share increase of 5% to $0.22; Non-GAAP diluted... More